Huron Consulting Group (HURN) Q4 2008 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2008 earnings summary
5 Nov, 2026Executive summary
FY08 revenue rose 22.0% to $615.5M, but net income fell 3.0% to $40.7M and diluted EPS declined 8.2% to $2.13.
Healthcare and legal demand drove growth, offsetting a 14.1% revenue decline in Accounting and Financial Consulting as large engagements wound down.
Stockamp expanded healthcare consulting from July; acquisition funding lifted year-end borrowings to $280.0M.
Financial highlights
Revenue increased 22.0% to $615.5M; operating income rose 9.4% to $91.6M, while operating margin declined to 14.9% from 16.6%.
Net income was $40.7M vs. $41.9M; diluted EPS was $2.13 vs. $2.32, including dilution from shares issued for Stockamp and the Wellspring amendment.
Direct costs rose 22.8% to $360.4M; SG&A grew 28.4% to $131.1M, including higher marketing, staffing, facilities, share compensation and bad-debt provision.
Operating cash flow increased to $101.2M from $55.9M, helped by faster collections and higher deferred revenue; investing cash outflow was $250.9M.
Outlook and guidance
2009 direct costs and operating expenses expected to rise; plans include hiring managing directors and select managers, associates and analysts, while using variable consultants as demand requires.
2009 capital expenditures estimated at $25.0M, mainly for leasehold improvements, computer equipment and software.
Internally generated liquidity and available revolver capacity expected to fund long-term growth, earn-outs, commitments and debt service; financing access remains dependent on profitability, receivables, leverage and credit-market conditions.
Latest events from Huron Consulting Group
- Revenue grew 29.9%, while FY06 margins faced hiring and client-bankruptcy pressures.HURN
Q4 2005 - Acquisitions drove 75% revenue growth, alongside rising costs, debt and execution risks.HURN
Q4 2007 - FY06 growth lifted revenue 39% and operating margin to 16.5%, alongside acquisition-led expansion.HURN
Q4 2006 - Revenue rose 9.6%, but impairment and restatement costs drove a $32.9M net loss.HURN
Q4 2009 - Operating income rebounded, but Health and Education softness and restatement risks persisted.HURN
Q4 2010 - FY11 growth lifted revenue and adjusted EBITDA, but Financial Consulting and legal exposure remained concerns.HURN
Q4 2011 - Revenue and earnings advanced, but Financial Consulting weakened sharply.HURN
Q4 2012 - Revenue and Adjusted EBITDA grew, but margins narrowed as Q4 Legal weakened.HURN
Q4 2014 - FY13 revenue rose 15.1%, with Healthcare growth driving higher operating earnings.HURN
Q4 2013